News & Analysis on Clinical Trial Services & Contract Research And Development
AMRI: Scott Waldman, SVP of corporate development
By Jenni Spinner
- Last updated on
Albany Molecular Research Inc. (AMRI) has appointed Scott Waldman senior vice president of corporate development. In his new role, Waldman is charged driving global growth initiatives, including mergers and acquisitions.
“We are delighted to welcome Scott to the AMRI organization to lead this critical function,” said John Ratliff, AMRI CEO. “Scott has built an impressive track record of delivering growth throughout his career; he knows the space and understands the inherent complexities of our business. I’m confident that Scott will be a key contributor to AMRI’s continued growth journey.”